HIV prevalence and diabetes prevalence among tuberculosis patients in Antananarivo city: a descriptive study

Julio Rakotonirina, Herilala Razanakoto, Laurence Rasolofomanana, Lala Rasoamialy-Sola Razanakolona

Abstract


Background: In developing countries, HIV infection is the main disease leads to tuberculosis (TB) active. Each tuberculosis (TB) patient of TB diagnosis and treatment centers in Antananarivo city should receive HIV serology counseling. The TB-diabetes association is rarely considered. In general population in Madagascar HIV was 0.37% in 2010 and Diabetes affects about 3% of the population. This study aims to estimate the prevalence of HIV infection and diabetes among TB patients.

Methods:A descriptive study in three TB diagnosis and treatment centers in Antananarivo city was conducted between July 15, 2013 and October 30, 2013. TB Patients aged 18 years and older were enrolled. They completed HIV and blood glucose testing after informed consent.

Results:Among 156 TB patients, one case is HIV positive [0.6% (0.1 - 3.6)] and two are indeterminate [1.3% (0.4 - 4.6)]. The HIV infection case relates to an extrapulmonary TB. Nine cases of diabetes were diagnosed [5.8% (3.1 - 10.6)], and four of them had their diabetes status before the study. Six diabetic are between 40 and 50 years. Among TB patients, diabetes prevalence is nine times higher than HIV prevalence (P = 0.01).

Conclusion:As for people living with HIV, diabetics should benefit TB prevention and routine screening of TB. Creating mechanism of collaboration between the diabetes program and TB program should be one of heath priorities.

 


Keywords


Tuberculosis, HIV, Diabetes, Antananarivo city

Full Text:

PDF

References


Lienhardt C. From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis. Epidemiol Rev. 2001;23(2):288-301.

Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38(2):199-205.

Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the VIH epidemic. Arch Intern Med. 2003;163(9):1009-21.

Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320(9):545-50.

Shafer RW, Singh SP, Larkin C, Small PM. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in an immunocompetent patient. Tuberc Lung Dis. 1995;76(6):575-7.

Martens GW, Arikan MC, Lee J, Ren F, Greiner D, Kornfeld H. Tuberculosis susceptibility of diabetic mice. Am J Resp Cell Molecul Biol. 2007;37(5):518–24.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabet Care. 2004;27:1047-53.

ONUSIDA. Le point sur l’épidémie du SIDA, 2006. Available at: http://data.unaids.org/pub/epireport/2006/2006_epiupdate_fr.pdf.

Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006;367:926-7.

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):1091-101.

Goldhaber-Fiebert JD, Christie YJ, Cohen T, Murray MB. Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants. Int J Epidemiol. 2011;40:417-28.

Rakotonirina EJ, Mahadimby JYN, Ravaoarisoa L, Rakotomanga JDM, Macq J. Etat des lieux de la lute contre la tuberculose à Madagascar de 1996 à 2004. Médecine Tropicale. 2009;69:493-5.

Ministère de la Santé Publique à Madagascar. Rapport d’activités sur la riposte au sida à Madagascar. Rapport, 2012. Available at: http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_MG_Narrative_Report.pdf.

Morvan JM, Auregan G, Rasamindrakotroka AJ, Roux JF. Infection à VIH chez les tuberculeux à Madagascar, situation en 1993. Arch Inst Pasteur Madagascar. 1994;61(2):73-5.

Secrétariat Exécutif du Comité National de Lutte contre le Sida. Prévalence du VIH/SIDA à Madagascar. SE/CNLS, 2006. Available at: http://www.sidaentreprises.org/fr/page.php?id_rub1=43&id_rub2=90&col=3.

World Health Organization. Non communicable diseases country profile. In: WHO, eds. WHO Profile. Geneva, Switzerland: WHO; 2011: 2-207.

World Health Organization. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis. 2001;5:213-5.

Programme National de Lutte Contre le Sida à Madagascar. Counseling et dépistage du VIH à Madagascar: normes et procédures. Edition, 2011. Available at: http://www.jica.go.jp/madagascar/french/office/others/pdf/publications02_03.pdf.

Drouin P, Blickle JF, Charbonnel B, Eschwege E, Guillausseau PJ, Plouin PF, et al. Diagnostic et classification du diabète sucré: les nouveaux critères. Diabètes et métabolisme. 1999;25:72-83.

Rocha C, Montoya R, Zevallos K, Curatola A, Ynga W, Franco J, et al. The innovative socio-economic interventions against tuberculosis (ISIAT) project: an operational assessment. Int J Tuberc Lung Dis. 2011;15(2):S50-7.

Ministère de la Santé Publique à Madagascar. Manuel du programme national de lutte contre la tuberculose à Madagascar. 5ème éd, 2013. Available at: http://www.sante.gov.mg/index.php/blog/21-missions-et-attributions/105-programme-national-de-lutte-contre-la-tuberculose.

Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005;19:2109-16.

World Health Organization. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. In: WHO, eds. WHO Guideline. Geneva, Switzerland: WHO; 2011: 1-39.